I

07630

IMPACT Therapeutics

9.115

+0.725+8.64%
Closed16:08 11/13 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE10.720/9.325
TODAY RANGE10.700-11.930
VOL12.29M
MARKET CAP3.05B
52 WEEK RANGE7.735-47.980
AVG VOL (3M)4.85M
% TURNOVER4.35%
TURNOVER138.39M
P/E (TTM)-10.260
% RANGE13.19%
EPS(TTM)-1.052
P/E(FORWARD)--
P/B3.412
BVPS3.162
DIVIDEND--
P/S22.395
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.05B
SHARES OUTSTANDING282.46M
NEXT EARNINGS--
FREE FLOAT282.46M
LOT SIZE200
EX-DATE--
Same Industry
Name/Symbol
Change%
Price

昊

昊海生物科技

06826

-0.26%
15.520

W

Wuxi Apptec

02359

-4.87%
191.600

H

Hangzhou Tigermed Consulting

03347

-3.21%
36.820

J

JOINN Laboratories (China)

06127

-7.70%
22.520

康

康龍化成

03759

-5.89%
28.100

F

Frontage Holdings

01521

-0.48%
2.075

01035

--

中

中國醫療集團

08225

0.00%
0.060

00233

--

中

中國再生醫學-舊

08572

0.00%
0.010

邁

邁博藥業-B

02181

0.00%
0.490

維

維亞生物

01873

-3.08%
1.260

中

中國再生醫學

08158

0.00%
0.240

東

東曜藥業-B

01875

+1.50%
3.390

華

華領醫藥-B

02552

-1.14%
2.175

微

微創腦科學

02172

0.00%
8.055

康

康寧傑瑞製藥-B

09966

-3.36%
5.745

中

中國抗體-B

03681

-4.50%
0.955

樂

樂普生物

02157

-3.57%
2.700

J

Jacobio Pharmaceuticals Group

01167

-6.04%
4.515

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities. This should not be construed as an investment advice and does not constitute an offer, solicitation, opinion, or any guarantee of any investment product, nor does it constitute any investment recommendation. Investments involve risks, Investment products prices are subject to fluctuation and may rise or fall (including the possibility of loss of the capital invested). Past performance is not indicative of future results. Before making any investment decision, investors should carefully consider your own risk tolerance, financial situation, investment experience, and objectives, or consult professional investment advisors to make a rational decision.
Language

English

©2026 Webull Securities Limited. All rights reserved.